Ovarian cancer in BRCA-positive women: vigilance is mandatory despite screening programs

A young BRCA-1 positive woman turned out to have advanced stage ovarian cancer despite an ensuring check-up 4 months earlier. Much remains unknown regarding the efficacy of screening programs, when applied to individuals predisposed for an inherited malignancy. Therefore, vigilance is mandatory when...

Full description

Saved in:
Bibliographic Details
Published in:European journal of obstetrics & gynecology and reproductive biology 2002-03, Vol.101 (2), p.196-198
Main Authors: Sloots, Karin, Ausems, Margreet G.E.M., de Haan, Harm H.
Format: Article
Language:English
Subjects:
Adult
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Biological and medical sciences
BRCA
Case report
Cisplatin - therapeutic use
Female
Genes, BRCA1
Gynecology. Andrology. Obstetrics
Humans
Hysterectomy
Mammary gland diseases
Mass Screening
Medical sciences
Mutation
Ovarian malignancy
Ovarian Neoplasms - diagnosis
Ovarian Neoplasms - pathology
Ovarian Neoplasms - therapy
Paclitaxel - therapeutic use
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A young BRCA-1 positive woman turned out to have advanced stage ovarian cancer despite an ensuring check-up 4 months earlier. Much remains unknown regarding the efficacy of screening programs, when applied to individuals predisposed for an inherited malignancy. Therefore, vigilance is mandatory when dealing with women with a positive family history of mammarian and/or ovarian cancer.
ISSN:0301-2115
1872-7654
DOI:10.1016/S0301-2115(01)00294-9